Inflammation, Inflammasome Activation, and Atrial Fibrillation.
作者信息
Van Wagoner David R, Chung Mina K
机构信息
Departments of Molecular Cardiology, Lerner Research Institute (D.R.V.W., M.K.C.), Cleveland Clinic, OH.
Cardiovascular Medicine, Heart and Vascular Institute (M.K.C.), Cleveland Clinic, OH.
出版信息
Circulation. 2018 Nov 13;138(20):2243-2246. doi: 10.1161/CIRCULATIONAHA.118.036143.
Abstract
摘要
相似文献
1
Inflammation, Inflammasome Activation, and Atrial Fibrillation.
Circulation. 2018 Nov 13;138(20):2243-2246. doi: 10.1161/CIRCULATIONAHA.118.036143.
2
Inflammasome activation in AF.
Nat Rev Cardiol. 2018 Aug;15(8):442. doi: 10.1038/s41569-018-0045-5.
3
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology.
Nat Rev Cardiol. 2023 Mar;20(3):145-167. doi: 10.1038/s41569-022-00759-w. Epub 2022 Sep 15.
4
[Research progress on the relationship between NLRP3 inflammasome and atrial fibrillation].
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Dec 24;49(12):1276-1280. doi: 10.3760/cma.j.cn112148-20210606-00477.
5
Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Am J Respir Cell Mol Biol. 2016 Feb;54(2):151-60. doi: 10.1165/rcmb.2015-0231TR.
6
Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling.
Circulation. 2018 Nov 27;138(22):2530-2544. doi: 10.1161/CIRCULATIONAHA.118.034621.
7
Inflammasome activation: unraveling the link between chronic kidney disease and atrial fibrillation.
Kidney Int. 2024 Jul;106(1):6-9. doi: 10.1016/j.kint.2024.01.033.
8
Increased M1 Macrophages Infiltration Is Associated with Thrombogenesis in Rheumatic Mitral Stenosis Patients with Atrial Fibrillation.
PLoS One. 2016 Mar 1;11(3):e0149910. doi: 10.1371/journal.pone.0149910. eCollection 2016.
9
Inflammasome biology, molecular pathology and therapeutic implications.
Pharmacol Ther. 2018 Jul;187:133-149. doi: 10.1016/j.pharmthera.2018.02.011. Epub 2018 Feb 18.
10
Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Arterioscler Thromb Vasc Biol. 2018 Dec;38(12):2765-2779. doi: 10.1161/ATVBAHA.118.311916.
引用本文的文献
1
IFNγ NKT-like cells are associated with increased incidence of atrial fibrillation in elderly women.
Eur Heart J Open. 2025 Jun 5;5(3):oeaf063. doi: 10.1093/ehjopen/oeaf063. eCollection 2025 May.
2
Biomarker and cognitive decline in atrial fibrillation: a prospective cohort study.
Sci Rep. 2025 Apr 15;15(1):12921. doi: 10.1038/s41598-025-89800-9.
3
Increased neprilysin expression is linked to atrial fibrotic remodeling in cardiovascular surgery patients.
Int J Cardiol Heart Vasc. 2025 Mar 17;57:101647. doi: 10.1016/j.ijcha.2025.101647. eCollection 2025 Apr.
4
Sex Differences in Atrial Fibrillation: Evidence from Circulating Metabolites.
Metabolites. 2025 Mar 2;15(3):170. doi: 10.3390/metabo15030170.
5
Role of ferroptosis in atrial fibrillation: a review.
Front Pharmacol. 2025 Feb 6;16:1362060. doi: 10.3389/fphar.2025.1362060. eCollection 2025.
6
Therapeutic Potential of Gasdermin D-Mediated Myocardial Pyroptosis in Ischaemic Heart Disease: Expanding the Paradigm From Bench to Clinical Insights.
J Cell Mol Med. 2025 Feb;29(3):e70357. doi: 10.1111/jcmm.70357.
7
Prevention of New-Onset Heart Failure in Atrial Fibrillation: The Role of Pharmacological Management.
Am J Cardiovasc Drugs. 2025 Mar;25(2):147-155. doi: 10.1007/s40256-024-00703-y. Epub 2024 Nov 24.
8
Amlexanox reduces new-onset atrial fibrillation risk in sepsis by downregulating S100A12: a Mendelian randomization study.
Front Cardiovasc Med. 2024 Oct 9;11:1401314. doi: 10.3389/fcvm.2024.1401314. eCollection 2024.
9
Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study.
JHEP Rep. 2024 Jul 18;6(10):101171. doi: 10.1016/j.jhepr.2024.101171. eCollection 2024 Oct.
10
Association between interleukin-6 levels and stroke: a systematic review and meta-analysis.
J Int Med Res. 2024 Sep;52(9):3000605241274626. doi: 10.1177/03000605241274626.
本文引用的文献
1
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.
Circulation. 2018 Nov 13;138(20):2227-2242. doi: 10.1161/CIRCULATIONAHA.118.035202.
2
Ion homeostasis and ion channels in NLRP3 inflammasome activation and regulation.
Curr Opin Immunol. 2018 Jun;52:8-17. doi: 10.1016/j.coi.2018.03.010. Epub 2018 Mar 16.
3
Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming.
Cell. 2018 Jan 11;172(1-2):162-175.e14. doi: 10.1016/j.cell.2017.12.013.
4
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.
Lancet. 2018 Jan 27;391(10118):319-328. doi: 10.1016/S0140-6736(17)32814-3. Epub 2017 Nov 13.
5
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
6
Modifiable Risk Factors and Atrial Fibrillation.
Circulation. 2017 Aug 8;136(6):583-596. doi: 10.1161/CIRCULATIONAHA.116.023163.
7
Cytosolic proteostasis through importing of misfolded proteins into mitochondria.
Nature. 2017 Mar 16;543(7645):443-446. doi: 10.1038/nature21695. Epub 2017 Mar 1.
8
Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence.
Circ Arrhythm Electrophysiol. 2015 Feb;8(1):32-41. doi: 10.1161/CIRCEP.114.001632. Epub 2014 Dec 18.
9
Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study.
Ann Intern Med. 2013 Dec 3;159(11):721-8. doi: 10.7326/0003-4819-159-11-201312030-00004.
10
Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.
JAMA. 2013 Nov 20;310(19):2050-60. doi: 10.1001/jama.2013.280521.
Zotero 插件